摘要
目的观察地奥司明片治疗ⅢA型前列腺炎患者的临床疗效。方法将70例符合ⅢA型前列腺炎诊断标准的患者随机分为两组,各35例。对照组患者给予口服盐酸多西环素片+盐酸坦洛新缓释胶囊治疗,治疗组患者给予口服地奥司明片+盐酸坦洛新缓释胶囊治疗。对治疗前及治疗4周后的美国国立卫生研究院慢性前列腺炎症状指数(NIH-CPSI评分),包括疼痛不适评分、排尿症状评分、生活质量评分进行对比。结果经治疗后,对照组与治疗组NIH-CPSI评分均较治疗前明显减少,差异具有统计学意义(P<0.05)。与对照组相比,治疗组能显著降低NIH-CPSI评分、疼痛不适评分、排尿症状评分、生活质量评分,其差异具有统计学意义(P<0.05)。治疗组总有效率为91.4%,明显高于对照组(77.1%),差异具有统计学意义(P<0.05)。结论地奥司明片在治疗ⅢA型前列腺炎方面疗效显著,能更好地改善ⅢA型前列腺炎患者的临床症状,值得临床推广应用。
Objective To observe the clinical curative effect of Diosmin in the treatment of type ⅢA prostatitis. Methods 70 patients diagnosed as type ⅢA prostatitis were randomly divided into treatment group(n=35)and control group(n=35). The control group was treated with combination therapy of doxycycline hydrochloride tabletsand Tamsulosin Hydrochloride sustained-release capsules, while the treatment group was treated with the combination of Diosmin tablet and Tamsulosin Hydrochloride sustained-release capsules. National Institutes of Health-Chronic Prostatitis Symptom Index(NIH-CPSI) was adopted to evaluate the pain and discomfort, urinary symptoms and life quality before and after four weeks′treatment in the two groups. Results After four weeks′ treatment, the scores of NIH-CPSI were reduced in both groups compared with those before treatment, with statisticallysignificant difference(P<0.05), and the decrease in the NIH-CPSI scores and scores of pain and discomfort, urinary symptoms and life quality was more significant than that in the control group, with statistically significant difference(P<0.05). The total effective rate of the treatment group(91.4%) was higher than that of the control group(77.1%), with statistically significant difference(P<0.05). Conclusions Diosmin tablet can significantly improve the clinical symptoms of IIIA prostatitis patients, which is worthy of clinical application.
作者
王梓阳
谢小平
WANG Ziyang;XIE Xiaoping(Urology Surgery, Guangdong Province Hospital of Integrated Traditional Chinese and Western Medicine Affil-iated to Guangzhou University of Traditional Chinese Medicine, Foshan528200, Guangdong, China)
出处
《中国性科学》
2019年第4期15-17,共3页
Chinese Journal of Human Sexuality
关键词
ⅢA型前列腺炎
地奥司明片
NIH-CPSI评分
临床疗效
ⅢA prostatitis
Diosmin tablet
National Institutes of Health-Chronic Prostatitis Symptom Index(NIH-CPSI)
Clinical curative effect
